[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1318 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. RES. 1318
Expressing support for the designation of the month of May 2026 as
``Progressive Supranuclear Palsy and Corticobasal Degeneration
Awareness Month''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 21, 2026
Mr. Subramanyam (for himself, Ms. Scanlon, Ms. Bonamici, Mr.
Walkinshaw, Mr. Quigley, Mr. Ryan, Mrs. Foushee, Ms. DelBene, Ms.
Barragan, Mr. Bacon, Ms. Scholten, Mr. Lawler, Ms. Garcia of Texas, Ms.
McClellan, Mr. Stanton, Mrs. Dingell, Ms. Castor of Florida, Mr.
Vindman, Mr. Beyer, Mr. Cleaver, Mrs. Fletcher, Mr. Pappas, Mr. Scott
of Virginia, Ms. Norton, Ms. Leger Fernandez, and Ms. Salinas)
submitted the following resolution; which was referred to the Committee
on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of the month of May 2026 as
``Progressive Supranuclear Palsy and Corticobasal Degeneration
Awareness Month''.
Whereas progressive supranuclear palsy, often referred to as ``PSP'', and
corticobasal degeneration, often referred to as ``CBD'', are rare, adult
onset, rapidly progressing neurodegenerative disorders that affect
multiple areas of the brain and cause complex symptoms and care needs;
Whereas although some symptoms may appear similar to that of other neurological
diagnoses like Parkinson's disease and frontotemporal dementia,
progressive supranuclear palsy and corticobasal degeneration are
distinct diseases with their own unique trajectories and care needs;
Whereas while estimates vary and the conditions are frequently misdiagnosed,
approximately 30,000 Americans are living with progressive supranuclear
palsy and 2,000 Americans are living with corticobasal degeneration;
Whereas delays to both accurate diagnosis of progressive supranuclear palsy and
corticobasal degeneration and access to neurology professionals
specialized in these diseases are common, causing confusion, anxiety,
and frustration;
Whereas progressive supranuclear palsy and corticobasal degeneration can cause
significant difficulty with movement, balance, speech, swallowing,
cognition, vision, mood, and a variety of other complex symptoms;
Whereas progressive supranuclear palsy and corticobasal degeneration are
aggressive in their progression, with most individuals becoming
dependent on care in 3 to 4 years and having an overall life expectancy
of 7 to 8 years from symptom onset;
Whereas there are currently no disease-modifying treatments for progressive
supranuclear palsy or corticobasal degeneration;
Whereas more research is needed to understand the roles of environmental factors
and genetics in why people develop progressive supranuclear palsy and
corticobasal degeneration;
Whereas there are countless family caregivers, friends, and loved ones whose
lives are greatly affected by progressive supranuclear palsy and
corticobasal degeneration;
Whereas additional research, support services, and education are needed to
maintain quality of life for those affected by the disease, lead to
better treatments and prevention of complications, and find cures for
progressive supranuclear palsy and corticobasal degeneration; and
Whereas the establishment of the month of May 2026 as ``Progressive Supranuclear
Palsy and Corticobasal Degeneration Awareness Month'' will benefit
individuals diagnosed, families, healthcare professionals, and
communities across the country and further bolster awareness of the
diseases: Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of ``Progressive Supranuclear
Palsy and Corticobasal Degeneration Awareness Month'';
(2) supports the goals and ideals of ``Progressive
Supranuclear Palsy and Corticobasal Degeneration Awareness
Month'';
(3) supports research on diagnosis, prevention, treatments,
and cures for progressive supranuclear palsy and corticobasal
degeneration;
(4) recognizes the strength and resilience of the
progressive supranuclear palsy and corticobasal degeneration
community; and
(5) commends the individuals, families, volunteers,
healthcare professionals, researchers, and organizations across
the country who are working to improve the lives of people
living with progressive supranuclear palsy and corticobasal
degeneration.
<all>